Dementia caregiving entails chronic, fluctuating stress with downstream risks to caregivers' mental health and quality of care. Mindfulness-based interventions can reduce caregiver stress; however, moment-to-moment fluctuations in stress may limit receptivity to practice at any given time. We developed a brief mindfulness just-in-time adaptive intervention (JITAI) that aims to deliver support...
OBJECTIVES: This study examined the effects of an age-adapted mindfulness-based cognitive therapy (MBCT) program on depression, anxiety, stress, mindfulness, and sleep quality among older adults. METHODS: A quasi-experimental pretest - posttest design with intervention and control groups was used. Sixty-two community-dwelling adults aged 60 years and older completed the study. The intervention...
Background: Burnout syndrome has become endemic to healthcare professions and is characterized by emotional exhaustion, depersonalization, and a diminished sense of accomplishment. The COVID-19 pandemic introduced additional burdens to pre-existing stressors and has left the global healthcare workforce, including those in India, with an ongoing psychological crisis. Objective: The aim of this...
FigshareJune 4, 2026Chan-Woo Yeom, Onyoo Kim, Jeong-A. Yu et al.
preprint
spinal cord injury (SCI) reduces quality of life and causes chronic inflammation. Mindfulness-based interventions may improve these symptoms. However, few studies have examined the benefits of mindfulness-based interventions in individuals with SCI. This study evaluated a tailored Mindfulness-Based Cognitive Therapy (MBCT) program. We conducted a non-randomized controlled trial at a national...
spinal cord injury (SCI) reduces quality of life and causes chronic inflammation. Mindfulness-based interventions may improve these symptoms. However, few studies have examined the benefits of mindfulness-based interventions in individuals with SCI. This study evaluated a tailored Mindfulness-Based Cognitive Therapy (MBCT) program. We conducted a non-randomized controlled trial at a national...
Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, was first approved by the US FDA as KETALAR® for induction and maintenance of general anesthesia. Ketamine has been used off-label for depression treatment, while its S-enantiomer, esketamine (SPRAVATO®), is approved for treatment-resistant depression and major depressive disorder with acute suicidal ideation or behavior. High doses...
OBJECTIVE Cannabis use is a known risk factor for psychosis, but it remains unclear whether cannabis-associated psychosis (CAP) differs meaningfully from non-cannabis-associated psychosis (NCAP) in clinical presentation, biology, or illness course. The objective of this study was to characterize the presentation and course of first-episode psychosis with and without cannabis exposure. METHODS...
Background: Polycystic Ovary Syndrome (PCOS), a prevalent metabolic and reproductive disorder, significantly impacts women of reproductive age. The conventional approach offers various symptomatic pharmacological interventions for PCOS, but some of them have adverse effects too. In this context, yoga has emerged as a promising non-pharmacological complementary approach. Aim: This systematic...
bioRxivJune 3, 2026Shuo Yang, Ling-Jun Wang, Yunxiang Sun et al.
preprint
Abstract A deeper understanding of the targets and mechanisms of fast-acting antidepressants, exemplified by ketamine, remains indispensable for better therapeutic strategies and understanding depression. Beyond the canonical neuron-centric NMDAR inhibition hypothesis, brain opioid system and glia-mediated processes are increasingly implicated in ketamine’s antidepressant efficacy, yet their...
CJEMJune 3, 2026Yury Onikashvili, Heather Burt, Garth Meckler et al.
ObjectivesEmergency department (ED) visits by adolescents with suicidal ideation have increased, with no rapid-acting treatments identified for ED use. This pilot study explored the feasibility of a randomized controlled trial of ketamine in the ED for adolescents with suicidal ideation.MethodsThree-arm, triple-blinded randomized controlled trial comparing intravenous ketamine (0.5 mg/kg),...